Redefining the biological basis of lineage-ambiguous leukemia through genomics: BCL11B deregulation in acute leukemias of ambiguous lineage

Acute leukemias of ambiguous lineage (ALAL), including mixed phenotype acute leukemia (MPAL) and related entities such as early T-cell precursor acute leukemia (ETP-ALL), remain diagnostic and clinical challenges due to limited understanding of pathogenesis, reliance of immunophenotyping to classify...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Best practice & research. Clinical haematology Ročník 34; číslo 4; s. 101329
Hlavní autoři: Montefiori, Lindsey E., Mullighan, Charles G.
Médium: Journal Article
Jazyk:angličtina
Vydáno: Netherlands Elsevier Ltd 01.12.2021
Témata:
14q32
ALAL
BCL11B
Child
Enhancer hijacking
Genomics
Humans
Immunophenotyping
Lineage ambiguous
Mixed phenotype acute leukemia
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Prospective Studies
Repressor Proteins
Tumor Suppressor Proteins
ALAL
BCL11B
Lineage ambiguous
14q32
Mixed phenotype acute leukemia
Enhancer hijacking
ISSN:1521-6926, 1532-1924, 1532-1924
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Abstract Acute leukemias of ambiguous lineage (ALAL), including mixed phenotype acute leukemia (MPAL) and related entities such as early T-cell precursor acute leukemia (ETP-ALL), remain diagnostic and clinical challenges due to limited understanding of pathogenesis, reliance of immunophenotyping to classify disease, and the lack of a rational approach to guide selection of appropriate therapy. Recent studies utilizing genomic sequencing and complementary approaches have provided key insights that are changing the way in which such leukemias are classified, and potentially, treated. Several recurrent genomic alterations define leukemias that straddle immunophenotypic entities, such as ZNF384-rearranged childhood B-ALL and B/myeloid MPAL, and BCL11B-rearranged T/myeloid MPAL, ETP-ALL and AML. In contrast, some cases of MPAL represent canonical ALL/AML entities exhibiting lineage aberrancy. For many cases of ALAL, experimental approaches indicate lineage aberrancy arises from acquisition of a founding genetic alteration into a hematopoietic stem or progenitor cell. Determination of optimal therapeutic approach requires genomic characterization of uniformly treated ALAL patients in prospective studies, but several approaches, including kinase inhibitors and BH3 mimetics may be efficacious in subsets of ALAL.
AbstractList Acute leukemias of ambiguous lineage (ALAL), including mixed phenotype acute leukemia (MPAL) and related entities such as early T-cell precursor acute leukemia (ETP-ALL), remain diagnostic and clinical challenges due to limited understanding of pathogenesis, reliance of immunophenotyping to classify disease, and the lack of a rational approach to guide selection of appropriate therapy. Recent studies utilizing genomic sequencing and complementary approaches have provided key insights that are changing the way in which such leukemias are classified, and potentially, treated. Several recurrent genomic alterations define leukemias that straddle immunophenotypic entities, such as ZNF384-rearranged childhood B-ALL and B/myeloid MPAL, and BCL11B-rearranged T/myeloid MPAL, ETP-ALL and AML. In contrast, some cases of MPAL represent canonical ALL/AML entities exhibiting lineage aberrancy. For many cases of ALAL, experimental approaches indicate lineage aberrancy arises from acquisition of a founding genetic alteration into a hematopoietic stem or progenitor cell. Determination of optimal therapeutic approach requires genomic characterization of uniformly treated ALAL patients in prospective studies, but several approaches, including kinase inhibitors and BH3 mimetics may be efficacious in subsets of ALAL.
Acute leukemias of ambiguous lineage (ALAL), including mixed phenotype acute leukemia (MPAL) and related entities such as early T-cell precursor acute leukemia (ETP-ALL), remain diagnostic and clinical challenges dues to limited understanding of pathogenesis, reliance of immunophenotyping to classify disease, and the lack of a rational approach to guide selection of appropriate therapy. Recent studies utilizing genomic sequencing and complementary approaches have provided key insights that are changing the way in which such leukemias are classified, and potentially, treated. Several recurrent genomic alterations define leukemias that straddle immunophenotypic entities, such as ZNF384-rearranged childhood B-ALL and B/myeloid MPAL, and BCL11B-rearranged T/myeloid MPAL, ETP-ALL and AML. In contrast, some cases of MPAL represent canonical ALL/AML entities exhibiting lineage aberrancy. For many cases of ALAL, experimental approaches indicate lineage aberrancy arises from acquisition of a founding genetic alterations into a hematopoietic stem and progenitor cell. Determination of optimal therapeutic approach requires genomic characterization of uniformly treated ALAL patients in prospective studies, but several approaches, including kinase inhibitors and BH3 mimetics may be efficacious in subsets of ALAL.
Acute leukemias of ambiguous lineage (ALAL), including mixed phenotype acute leukemia (MPAL) and related entities such as early T-cell precursor acute leukemia (ETP-ALL), remain diagnostic and clinical challenges due to limited understanding of pathogenesis, reliance of immunophenotyping to classify disease, and the lack of a rational approach to guide selection of appropriate therapy. Recent studies utilizing genomic sequencing and complementary approaches have provided key insights that are changing the way in which such leukemias are classified, and potentially, treated. Several recurrent genomic alterations define leukemias that straddle immunophenotypic entities, such as ZNF384-rearranged childhood B-ALL and B/myeloid MPAL, and BCL11B-rearranged T/myeloid MPAL, ETP-ALL and AML. In contrast, some cases of MPAL represent canonical ALL/AML entities exhibiting lineage aberrancy. For many cases of ALAL, experimental approaches indicate lineage aberrancy arises from acquisition of a founding genetic alteration into a hematopoietic stem or progenitor cell. Determination of optimal therapeutic approach requires genomic characterization of uniformly treated ALAL patients in prospective studies, but several approaches, including kinase inhibitors and BH3 mimetics may be efficacious in subsets of ALAL.Acute leukemias of ambiguous lineage (ALAL), including mixed phenotype acute leukemia (MPAL) and related entities such as early T-cell precursor acute leukemia (ETP-ALL), remain diagnostic and clinical challenges due to limited understanding of pathogenesis, reliance of immunophenotyping to classify disease, and the lack of a rational approach to guide selection of appropriate therapy. Recent studies utilizing genomic sequencing and complementary approaches have provided key insights that are changing the way in which such leukemias are classified, and potentially, treated. Several recurrent genomic alterations define leukemias that straddle immunophenotypic entities, such as ZNF384-rearranged childhood B-ALL and B/myeloid MPAL, and BCL11B-rearranged T/myeloid MPAL, ETP-ALL and AML. In contrast, some cases of MPAL represent canonical ALL/AML entities exhibiting lineage aberrancy. For many cases of ALAL, experimental approaches indicate lineage aberrancy arises from acquisition of a founding genetic alteration into a hematopoietic stem or progenitor cell. Determination of optimal therapeutic approach requires genomic characterization of uniformly treated ALAL patients in prospective studies, but several approaches, including kinase inhibitors and BH3 mimetics may be efficacious in subsets of ALAL.
ArticleNumber 101329
Author Mullighan, Charles G.
Montefiori, Lindsey E.
AuthorAffiliation 1 Department of Pathology, St. Jude Children’s Research Hospital, Memphis TN, US
AuthorAffiliation_xml – name: 1 Department of Pathology, St. Jude Children’s Research Hospital, Memphis TN, US
Author_xml – sequence: 1
  givenname: Lindsey E.
  surname: Montefiori
  fullname: Montefiori, Lindsey E.
– sequence: 2
  givenname: Charles G.
  surname: Mullighan
  fullname: Mullighan, Charles G.
  email: charles.mullighan@stjude.org
BackLink https://www.ncbi.nlm.nih.gov/pubmed/34865701$$D View this record in MEDLINE/PubMed
BookMark eNqFkstuFDEQRVsoiDzgB1ggL9n0xI9-RgiJjIAgjYSEYG35Ud1Tk2472N2R8g38NO5MEoUswsqWq869qro-zg6cd5BlbxldMcqq091Kw1atOOVseRC8fZEdsVLwnLW8OFjunOVVy6vD7DjGHaVCtFy8yg5F0VRlTdlR9ucHWOjQoevJtAWi0Q--R6MGolXESHxHBnSgesjVqLGf_RzJAPMljKgSEvzcb0kPzo9o4hk5X28YOycWAvTzoCb0jqAjyswTPHC3so_k9gavs5edGiK8uTtPsl9fPv9cX-Sb71-_rT9tclPSasrLrrFFne5UcNNoXRqrRdFWtu102Wmh02TGpGJdKlbzri6sBa55YznQ1nJxkn3c617NegRrwE1BDfIq4KjCjfQK5b8Vh1vZ-2vZVEXL6iIJvL8TCP73DHGSI0YDw6AcpHkkr2gtGCsES63vHns9mNwnkBqafYMJPsYAnTQ43a4tWeMgGZVL2HInl7DlErbch51Q_gS9V38W-rCHIG34GiHIaBCcAYsBzCStx-fxsye4Sekt_-USbv4H_wULvNj9
CitedBy_id crossref_primary_10_1097_BS9_0000000000000204
crossref_primary_10_3390_cancers14194914
crossref_primary_10_1016_j_mpdhp_2025_07_001
crossref_primary_10_1182_blood_2023020678
crossref_primary_10_1186_s13073_023_01241_z
crossref_primary_10_1016_j_medcle_2025_106917
crossref_primary_10_1093_jncics_pkaf065
crossref_primary_10_1002_pbc_30573
crossref_primary_10_1182_blood_2022015853
crossref_primary_10_1002_cyto_b_22205
crossref_primary_10_1038_s41375_022_01613_1
crossref_primary_10_3390_cancers17050871
crossref_primary_10_1016_j_medcli_2025_106917
crossref_primary_10_1016_j_lrr_2023_100410
Cites_doi 10.1038/sj.onc.1210152
10.1182/blood-2016-07-725861
10.1182/blood-2010-10-314682
10.1056/NEJMoa1516192
10.2147/CMAR.S196574
10.1182/bloodadvances.2018023531
10.3892/ijo.2014.2291
10.1101/cshperspect.a014282
10.1200/JCO.2011.34.7898
10.1182/blood.V67.1.1.1
10.1038/nmeth.3999
10.1182/blood.V63.6.1324.1324
10.1038/sj.leu.2404128
10.1111/bjh.15129
10.1038/nature25193
10.1038/s41375-020-0965-z
10.1158/2159-8290.CD-20-1465
10.1158/0008-5472.CAN-07-5836
10.1038/leu.2017.70
10.1038/ng.3909
10.3324/haematol.2009.014506
10.1182/blood.2019004684
10.1038/s41375-020-0761-9
10.1038/nm.3665
10.1038/nature13379
10.1186/s13045-014-0051-y
10.1182/blood-2011-09-380444
10.1038/nature11247
10.1016/j.cell.2013.03.036
10.1016/j.cancergencyto.2008.04.010
10.1016/j.cell.2017.09.001
10.1056/NEJMoa1614359
10.1002/pbc.27265
10.1182/blood-2008-10-187351
10.1016/S1470-2045(15)00362-9
10.1038/s41590-018-0238-4
10.1038/sj.leu.2405084
10.1158/2159-8290.CD-14-0353
10.1080/10428194.2017.1372577
10.1182/blood-2009-03-208397
10.1016/0165-4608(96)00030-1
10.1101/gad.232710.113
10.1182/blood-2012-11-465138
10.1038/s41467-021-21255-8
10.1016/j.cell.2015.04.004
10.1016/S1470-2045(17)30416-3
10.3324/haematol.2013.095604
10.1182/blood-2010-11-318873
10.1084/jem.20190972
10.1182/blood-2012-08-447839
10.1016/j.exphem.2016.05.003
10.1038/s41467-018-04924-z
10.3389/fimmu.2021.669498
10.1038/s41588-020-0659-5
10.1182/blood-2009-09-245944
10.1016/S0165-4608(03)00302-9
10.1056/NEJMoa1301689
10.1073/pnas.0903142106
10.1158/2159-8290.CD-17-0797
10.1056/NEJMoa040465
10.1016/j.molcel.2021.04.014
10.1016/j.cell.2014.02.019
10.1038/ni.3514
10.1016/j.cell.2013.03.035
10.1084/jem.20070863
10.1038/leu.2010.202
10.1016/S1470-2045(08)70314-0
10.1158/1078-0432.CCR-15-1349
10.1038/nature10725
10.1182/blood-2016-03-643544
10.1016/S0006-291X(02)03069-3
10.1016/j.molcel.2020.04.018
10.1038/nature07829
10.1038/nm.2246
10.1182/blood-2004-03-0891
10.1038/s41586-018-0436-0
10.1038/nbt.3158
10.1038/s41375-018-0058-4
10.3324/haematol.2016.151035
10.1126/science.1188989
10.1126/science.1188063
10.3324/haematol.2012.064485
10.1016/S0165-4608(02)00790-2
10.1007/s00277-012-1537-8
10.1038/nrc.2016.63
10.1038/nm.4439
10.1038/318533a0
10.1371/journal.pone.0053190
10.1038/leu.2014.55
10.1016/j.ccr.2014.02.008
10.1182/blood.V76.1.150.150
10.1080/10428194.2020.1802451
ContentType Journal Article
Copyright 2021 Elsevier Ltd
Copyright © 2021 Elsevier Ltd. All rights reserved.
Copyright_xml – notice: 2021 Elsevier Ltd
– notice: Copyright © 2021 Elsevier Ltd. All rights reserved.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOI 10.1016/j.beha.2021.101329
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE


MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1532-1924
EndPage 101329
ExternalDocumentID PMC8649174
34865701
10_1016_j_beha_2021_101329
S1521692621000943
Genre Review
Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NCI NIH HHS
  grantid: F32 CA254140
– fundername: NIGMS NIH HHS
  grantid: P50 GM115279
– fundername: NCI NIH HHS
  grantid: R35 CA197695
– fundername: NCI NIH HHS
  grantid: T32 CA236748
GroupedDBID ---
--K
--M
.1-
.FO
.~1
0R~
1B1
1P~
1RT
1~.
1~5
23N
4.4
457
4CK
4G.
53G
5GY
5VS
6J9
7-5
71M
8P~
AAEDT
AAEDW
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AATTM
AAXKI
AAXUO
AAYWO
ABBQC
ABGSF
ABMAC
ABMZM
ABUDA
ABWVN
ABXDB
ACDAQ
ACGFS
ACIEU
ACLOT
ACRLP
ACRPL
ACVFH
ADBBV
ADCNI
ADEZE
ADMUD
ADNMO
ADUVX
AEBSH
AEHWI
AEIPS
AEKER
AENEX
AEUPX
AEVXI
AFJKZ
AFPUW
AFRHN
AFTJW
AFXIZ
AGHFR
AGQPQ
AGRDE
AGUBO
AGYEJ
AIEXJ
AIGII
AIIUN
AIKHN
AITUG
AJRQY
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
APXCP
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
CAG
COF
DU5
EBS
EFJIC
EFKBS
EFLBG
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-Q
GBLVA
HVGLF
HZ~
IHE
J1W
KOM
M41
MO0
N9A
O-L
O9-
OAUVE
OC~
OO-
OZT
P-8
P-9
PC.
Q38
R2-
ROL
RPZ
SCC
SDF
SDG
SEL
SES
SEW
SPCBC
SSH
SSU
SSZ
T5K
UHS
Z5R
~G-
~HD
AACTN
AAIAV
ABLVK
ABYKQ
AFKWA
AJBFU
AJOXV
AMFUW
DOVZS
LCYCR
RIG
9DU
AAYXX
CITATION
AFCTW
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
ID FETCH-LOGICAL-c506t-5f8d47c50032c8bb5cdb3496d9fb5fb3b570cc03275a172f74dde2b28d2e09d23
ISICitedReferencesCount 14
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000727210100012&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1521-6926
1532-1924
IngestDate Tue Sep 30 17:17:53 EDT 2025
Thu Sep 25 09:02:55 EDT 2025
Thu Apr 03 07:04:00 EDT 2025
Sat Nov 29 07:04:22 EST 2025
Tue Nov 18 22:08:12 EST 2025
Fri Feb 23 02:41:10 EST 2024
Tue Oct 14 19:25:41 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords ALAL
BCL11B
Lineage ambiguous
14q32
Mixed phenotype acute leukemia
Enhancer hijacking
Language English
License Copyright © 2021 Elsevier Ltd. All rights reserved.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c506t-5f8d47c50032c8bb5cdb3496d9fb5fb3b570cc03275a172f74dde2b28d2e09d23
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/8649174
PMID 34865701
PQID 2607311431
PQPubID 23479
PageCount 1
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_8649174
proquest_miscellaneous_2607311431
pubmed_primary_34865701
crossref_citationtrail_10_1016_j_beha_2021_101329
crossref_primary_10_1016_j_beha_2021_101329
elsevier_sciencedirect_doi_10_1016_j_beha_2021_101329
elsevier_clinicalkey_doi_10_1016_j_beha_2021_101329
PublicationCentury 2000
PublicationDate 2021-12-01
PublicationDateYYYYMMDD 2021-12-01
PublicationDate_xml – month: 12
  year: 2021
  text: 2021-12-01
  day: 01
PublicationDecade 2020
PublicationPlace Netherlands
PublicationPlace_xml – name: Netherlands
PublicationTitle Best practice & research. Clinical haematology
PublicationTitleAlternate Best Pract Res Clin Haematol
PublicationYear 2021
Publisher Elsevier Ltd
Publisher_xml – name: Elsevier Ltd
References Pallavajjala, Kim, Li, Ghiaur, Jones, Burns (bib68) 2018; 59
Schwartz, Ma, Kamens, Westover, Walsh, Brady (bib48) 2021; 12
Riedel, Lu, Xie, Nestler, Vermunt, Lenard (bib45) 2021; 81
Gutierrez, Kentsis (bib13) 2018; 180
Stone, DeAngelo, Klimek, Galinsky, Estey, Nimer (bib86) 2005; 105
Lovén, Hoke, Lin, Lau, Orlando, Vakoc (bib42) 2013; 153
Hirabayashi, Ohki, Nakabayashi, Ichikawa, Momozawa, Okamura (bib18) 2017; 102
Neumann, Heesch, Schlee, Schwartz, Gökbuget, Hoelzer (bib85) 2013; 121
Tsao, Shi, Kornblau, Lu, Konoplev, Antony (bib91) 2012; 91
Zhong, Prima, Liang, Frye, McGavran, Meltesen (bib17) 2008; 22
Yang, Safavi, Woodward, Duployez, Olsson-Arvidsson, Ungerbäck (bib49) 2020; 136
Roberts, Seymour, Brown, Wierda, Kipps, Khaw (bib93) 2012; 30
Takahashi, Wang, Morita, Yan, Hu, Zhao (bib16) 2018; 9
Zhou, Li, Zhang, Lowdon, Rockweiler, Sears (bib39) 2015; 33
Alexander, Gu, Iacobucci, Dickerson, Choi, Xu (bib12) 2018; 562
Bezrookove, Van Zelderen-Bhola, Brink, Szuhai, Raap, Barge (bib63) 2004; 149
Chonghaile, Roderick, Glenfield, Ryan, Sallan, Silverman (bib95) 2014; 4
Albu, Feng, Bhattacharya, Jenkins, Copeland, Liu (bib28) 2007; 204
Andrews, Lam, Sibai (bib90) 2020; 61
Yan, Ping, Zhu, Sun, Xue, Ruan (bib3) 2012; 97
Wang, Beird, Kroll, Hu, Bueso-Ramos, Fang (bib69) 2020; 34
Gröschel, Sanders, Hoogenboezem, De Wit, Bouwman, Erpelinck (bib47) 2014; 157
Shi, Whyte, Zepeda-Mendoza, Milazzo, Shen, Roe (bib56) 2013; 27
Li, Leid, Rothenberg (bib30) 2010; 80
Li, Burke, Wang, Chen, Ortiz, Lee (bib29) 2010; 80
Bolouri, Farrar, Triche, Ries, Lim, Alonzo (bib83) 2018; 24
Wu, Kuo, Chen, Chen, Quinn (bib62) 2003; 141
Leverson, Sampath, Souers, Rosenberg, Fairbrother, Amiot (bib94) 2017; 7
Hosokawa, Romero-Wolf, Yang, Motomura, Levanon, Groner (bib27) 2020; 217
Harvey, Mullighan, Chen, Wharton, Mikhail, Carroll (bib54) 2010; 115
Bahr, von Paleske, Uslu, Remeseiro, Takayama, Ng (bib57) 2018; 553
Coustan-Smith, Mullighan, Onciu, Behm, Raimondi, Pei (bib7) 2009; 10
Bond, Krzywon, Lhermitte, Roumier, Anne, Belhocine (bib14) 2021; 35
Owaidah, Al Beihany, Iqbal, Elkum, Roberts (bib1) 2006; 20
Eckstein, Wang, Punia, Kornblau, Andreeff, Wheeler (bib84) 2016; 44
Maruffi, Sposto, Oberley, Kysh, Orgel (bib77) 2018; 32
Belver, Ferrando (bib50) 2016; 16
Kueh, Yui, Ng, Pease, Zhang, Damle (bib24) 2016; 17
Zhang, Jeong, Huang, Wang, Wang, Zhou (bib41) 2020; 78
Kühn, Radtke, Bullinger, Goorha, Cheng, Edelmann (bib59) 2012; 119
Smith, McCulloch (bib72) 1984; 63
Valk, Verhaak, Beijen, Erpelinck, Barjesteh van Waalwijk van Doorn-Khosrovani, Boer (bib21) 2004; 350
Di Giacomo, La Starza, Gorello, Pellanera, Kalender Atak, De Keersmaecker (bib70) 2021; 138
Numan, Alfayez, Maiti, Alvarado, Jabbour, Ferrajoli (bib96) 2018; 1–6
Li, Zhang, Dose, Kueh, Mosadeghi, Gounari (bib75) 2013; 122
(bib40) 2012; 489
Isoda, Moore, He, Chandra, Aida, Denholtz (bib76) 2017; 171
Noronha, Marques, Andrade, Sardou-Cezar, Santos-Bueno, Da Paz Zampier (bib9) 2019; 11
Hosokawa, Romero-Wolf, Yui, Ungerbäck, Quiloan, Matsumoto (bib26) 2018; 19
Kihara, Nagata, Kiyoi, Kato, Yamamoto, Suzuki (bib80) 2014; 28
Röllig, Serve, Hüttmann, Noppeney, Müller-Tidow, Krug (bib87) 2015; 16
Matutes, Pickl, Veer, Morilla, Swansbury, Strobl (bib5) 2011; 117
Hayashi, Pui, Behm, Fuchs, Raimondi, Kitchingman (bib60) 1990; 76
Radtke, Mullighan, Ishii, Su, Cheng, Ma (bib58) 2009; 106
Northcott, Lee, Zichner, Stütz, Erkek, Kawauchi (bib36) 2014; 511
Whyte, Orlando, Hnisz, Abraham, Lin, Kagey (bib43) 2013; 153
Wakabayashi, Inoue, Takahashi, Matsuki, Kosugi-Okano, Shinbo (bib31) 2003; 301
Perl, Altman, Cortes, Smith, Litzow, Baer (bib88) 2017; 18
Greaves, Chan, Furley, Watt, Molgaard (bib71) 1986; 67
Liu, Easton, Shao, Maciaszek, Wang, Wilkinson (bib11) 2017; 49
Schmitz, Ceribelli, Pittaluga, Wright, Staudt (bib52) 2014; 4
The Cancer Genome Atlas Research Network (bib79) 2013; 368
Batanian, Dunphy, Gale, Havlioglu (bib61) 1996; 90
Yamazaki, Suzuki, Otsuki, Shimizu, Bresnick, Engel (bib46) 2014; 25
Zhang, Ding, Holmfeldt, Wu, Heatley, Payne-Turner (bib8) 2012; 481
Georgy, Yonescu, Griffin, Batista (bib64) 2008; 185
Lupiáñez, Kraft, Heinrich, Krawitz, Brancati, Klopocki (bib37) 2015; 161
Rubnitz, Onciu, Pounds, Shurtleff, Cao, Raimondi (bib4) 2009; 113
Gu, Churchman, Roberts, Moore, Zhou, Nakitandwe (bib20) 2019; 1
Arber, Orazi, Hasserjian, Thiele, Borowitz, Le Beau (bib6) 2016; 127
Oberley, Gaynon, Bhojwani, Pulsipher, Gardner, Hiemenz (bib73) 2018; 65
Neumann, Coskun, Fransecky, Mochmann, Bartram, Farhadi Sartangi (bib10) 2013; 8
Mumbach, Rubin, Flynn, Dai, Khavari, Greenleaf (bib44) 2016
Pullarkat, Lacayo, Jabbour, Rubnitz, Bajel, Laetsch (bib97) 2021; 11
Grabarczyk, Przybylski, Depke, Völker, Bahr, Assmus (bib35) 2007; 26
Tse, Shoemaker, Adickes, Anderson, Chen, Jin (bib92) 2008; 68
Montefiori, Bendig, Gu, Chen, Polonen, Ma (bib19) 2021
Sidwell, Rothenberg (bib25) 2021; 12
Gutierrez, Kentsis, Sanda, Holmfeldt, Chen, Zhang (bib33) 2011; 118
Kobayashi, Taki, Nagoshi, Chinen, Yokokawa, Kanegane (bib66) 2014; 44
Liu, Li, Shen, Chen, Szlachta, Edmonson (bib22) 2020; 52
Papaemmanuil, Gerstung, Bullinger, Gaidzik, Paschka, Roberts (bib81) 2016; 374
Adams, Harris, Pinkert, Corcoran, Alexander, Cory (bib51) 1985; 318
Mejstrikova, Volejnikova, Fronkova, Zdrahalova, Kalina, Sterba (bib78) 2010; 95
Ha, Luong, Li, Casero, Malvar, Kim (bib23) 2017; 31
Heintzman, Hon, Hawkins, Kheradpour, Stark, Harp (bib38) 2009; 459
Zhao, Gojo, York, Ning, Baer (bib65) 2010; 3
Abbas, Sanders, Zeilemaker, Geertsma-Kleinekoort, Koenders, Kavelaars (bib67) 2014; 99
Xiao, Bharadwaj, Levine, Farnhoud, Pastore, Getta (bib15) 2018; 2
Kotrova, Musilova, Stuchly, Fiser, Starkova, Mejstrikova (bib74) 2016; 128
Bartram, Gökbuget, Schlee, Heesch, Fransecky, Schwartz (bib34) 2014; 7
Weinberg, Arber (bib2) 2010; 24
De Keersmaecker, Real, Gatta, Palomero, Sulis, Tosello (bib32) 2010; 16
Herranz, Ambesi-Impiombato, Palomero, Schnell, Belver, Wendorff (bib55) 2014; 20
Stone, Mandrekar, Sanford, Laumann, Geyer, Bloomfield (bib89) 2017; 377
Russell, Capasso, Vater, Akasaka, Bernard, Calasanz (bib53) 2009; 114
Tarlock, Alonzo, Gerbing, Raimondi, Hirsch, Sung (bib82) 2016; 22
Gutierrez (10.1016/j.beha.2021.101329_bib13) 2018; 180
Bartram (10.1016/j.beha.2021.101329_bib34) 2014; 7
Tarlock (10.1016/j.beha.2021.101329_bib82) 2016; 22
Pullarkat (10.1016/j.beha.2021.101329_bib97) 2021; 11
Tsao (10.1016/j.beha.2021.101329_bib91) 2012; 91
Neumann (10.1016/j.beha.2021.101329_bib10) 2013; 8
Zhang (10.1016/j.beha.2021.101329_bib41) 2020; 78
Zhang (10.1016/j.beha.2021.101329_bib8) 2012; 481
Isoda (10.1016/j.beha.2021.101329_bib76) 2017; 171
Kühn (10.1016/j.beha.2021.101329_bib59) 2012; 119
Liu (10.1016/j.beha.2021.101329_bib22) 2020; 52
Montefiori (10.1016/j.beha.2021.101329_bib19) 2021
Russell (10.1016/j.beha.2021.101329_bib53) 2009; 114
Yan (10.1016/j.beha.2021.101329_bib3) 2012; 97
Stone (10.1016/j.beha.2021.101329_bib89) 2017; 377
Owaidah (10.1016/j.beha.2021.101329_bib1) 2006; 20
Hosokawa (10.1016/j.beha.2021.101329_bib26) 2018; 19
Eckstein (10.1016/j.beha.2021.101329_bib84) 2016; 44
Gu (10.1016/j.beha.2021.101329_bib20) 2019; 1
Belver (10.1016/j.beha.2021.101329_bib50) 2016; 16
Kueh (10.1016/j.beha.2021.101329_bib24) 2016; 17
Zhong (10.1016/j.beha.2021.101329_bib17) 2008; 22
Batanian (10.1016/j.beha.2021.101329_bib61) 1996; 90
Lovén (10.1016/j.beha.2021.101329_bib42) 2013; 153
Xiao (10.1016/j.beha.2021.101329_bib15) 2018; 2
Zhou (10.1016/j.beha.2021.101329_bib39) 2015; 33
Bahr (10.1016/j.beha.2021.101329_bib57) 2018; 553
Roberts (10.1016/j.beha.2021.101329_bib93) 2012; 30
Weinberg (10.1016/j.beha.2021.101329_bib2) 2010; 24
(10.1016/j.beha.2021.101329_bib40) 2012; 489
Kobayashi (10.1016/j.beha.2021.101329_bib66) 2014; 44
Liu (10.1016/j.beha.2021.101329_bib11) 2017; 49
Maruffi (10.1016/j.beha.2021.101329_bib77) 2018; 32
Rubnitz (10.1016/j.beha.2021.101329_bib4) 2009; 113
Di Giacomo (10.1016/j.beha.2021.101329_bib70) 2021; 138
Andrews (10.1016/j.beha.2021.101329_bib90) 2020; 61
Numan (10.1016/j.beha.2021.101329_bib96) 2018; 1–6
Kihara (10.1016/j.beha.2021.101329_bib80) 2014; 28
Bolouri (10.1016/j.beha.2021.101329_bib83) 2018; 24
Bezrookove (10.1016/j.beha.2021.101329_bib63) 2004; 149
Radtke (10.1016/j.beha.2021.101329_bib58) 2009; 106
Kotrova (10.1016/j.beha.2021.101329_bib74) 2016; 128
Hirabayashi (10.1016/j.beha.2021.101329_bib18) 2017; 102
Heintzman (10.1016/j.beha.2021.101329_bib38) 2009; 459
Schwartz (10.1016/j.beha.2021.101329_bib48) 2021; 12
Zhao (10.1016/j.beha.2021.101329_bib65) 2010; 3
Tse (10.1016/j.beha.2021.101329_bib92) 2008; 68
Li (10.1016/j.beha.2021.101329_bib30) 2010; 80
Arber (10.1016/j.beha.2021.101329_bib6) 2016; 127
Shi (10.1016/j.beha.2021.101329_bib56) 2013; 27
Stone (10.1016/j.beha.2021.101329_bib86) 2005; 105
Valk (10.1016/j.beha.2021.101329_bib21) 2004; 350
Greaves (10.1016/j.beha.2021.101329_bib71) 1986; 67
Coustan-Smith (10.1016/j.beha.2021.101329_bib7) 2009; 10
Northcott (10.1016/j.beha.2021.101329_bib36) 2014; 511
The Cancer Genome Atlas Research Network (10.1016/j.beha.2021.101329_bib79) 2013; 368
Riedel (10.1016/j.beha.2021.101329_bib45) 2021; 81
Perl (10.1016/j.beha.2021.101329_bib88) 2017; 18
Sidwell (10.1016/j.beha.2021.101329_bib25) 2021; 12
Grabarczyk (10.1016/j.beha.2021.101329_bib35) 2007; 26
Yang (10.1016/j.beha.2021.101329_bib49) 2020; 136
Herranz (10.1016/j.beha.2021.101329_bib55) 2014; 20
Oberley (10.1016/j.beha.2021.101329_bib73) 2018; 65
Whyte (10.1016/j.beha.2021.101329_bib43) 2013; 153
Neumann (10.1016/j.beha.2021.101329_bib85) 2013; 121
Li (10.1016/j.beha.2021.101329_bib29) 2010; 80
Albu (10.1016/j.beha.2021.101329_bib28) 2007; 204
Ha (10.1016/j.beha.2021.101329_bib23) 2017; 31
Lupiáñez (10.1016/j.beha.2021.101329_bib37) 2015; 161
Smith (10.1016/j.beha.2021.101329_bib72) 1984; 63
Papaemmanuil (10.1016/j.beha.2021.101329_bib81) 2016; 374
Adams (10.1016/j.beha.2021.101329_bib51) 1985; 318
Georgy (10.1016/j.beha.2021.101329_bib64) 2008; 185
Abbas (10.1016/j.beha.2021.101329_bib67) 2014; 99
Alexander (10.1016/j.beha.2021.101329_bib12) 2018; 562
Gutierrez (10.1016/j.beha.2021.101329_bib33) 2011; 118
Matutes (10.1016/j.beha.2021.101329_bib5) 2011; 117
Bond (10.1016/j.beha.2021.101329_bib14) 2021; 35
Wakabayashi (10.1016/j.beha.2021.101329_bib31) 2003; 301
Harvey (10.1016/j.beha.2021.101329_bib54) 2010; 115
Mejstrikova (10.1016/j.beha.2021.101329_bib78) 2010; 95
Leverson (10.1016/j.beha.2021.101329_bib94) 2017; 7
Wang (10.1016/j.beha.2021.101329_bib69) 2020; 34
Hayashi (10.1016/j.beha.2021.101329_bib60) 1990; 76
Schmitz (10.1016/j.beha.2021.101329_bib52) 2014; 4
Chonghaile (10.1016/j.beha.2021.101329_bib95) 2014; 4
Hosokawa (10.1016/j.beha.2021.101329_bib27) 2020; 217
Li (10.1016/j.beha.2021.101329_bib75) 2013; 122
Takahashi (10.1016/j.beha.2021.101329_bib16) 2018; 9
Wu (10.1016/j.beha.2021.101329_bib62) 2003; 141
Mumbach (10.1016/j.beha.2021.101329_bib44) 2016
Pallavajjala (10.1016/j.beha.2021.101329_bib68) 2018; 59
De Keersmaecker (10.1016/j.beha.2021.101329_bib32) 2010; 16
Noronha (10.1016/j.beha.2021.101329_bib9) 2019; 11
Röllig (10.1016/j.beha.2021.101329_bib87) 2015; 16
Yamazaki (10.1016/j.beha.2021.101329_bib46) 2014; 25
Gröschel (10.1016/j.beha.2021.101329_bib47) 2014; 157
References_xml – volume: 22
  start-page: 723
  year: 2008
  end-page: 729
  ident: bib17
  article-title: E2A-ZNF384 and NOL1-E2A fusion created by a cryptic t(12;19)(p13.3; p13.3) in acute leukemia
  publication-title: Leukemia
– volume: 65
  year: 2018
  ident: bib73
  article-title: Myeloid lineage switch following chimeric antigen receptor T-cell therapy in a patient with TCF3-ZNF384 fusion-positive B-lymphoblastic leukemia
  publication-title: Pediatr Blood Cancer
– volume: 204
  start-page: 3003
  year: 2007
  ident: bib28
  article-title: BCL11B is required for positive selection and survival of double-positive thymocytes
  publication-title: J Exp Med
– volume: 59
  start-page: 1231
  year: 2018
  end-page: 1238
  ident: bib68
  article-title: Genomic characterization of chromosome translocations in patients with T/myeloid mixed-phenotype acute leukemia
  publication-title: Leuk Lymphoma
– volume: 16
  start-page: 1691
  year: 2015
  end-page: 1699
  ident: bib87
  article-title: Addition of sorafenib versus placebo to standard therapy in patients aged 60 years or younger with newly diagnosed acute myeloid leukaemia (SORAML): a multicentre, phase 2, randomised controlled trial
  publication-title: Lancet Oncol
– volume: 44
  start-page: 740
  year: 2016
  end-page: 744
  ident: bib84
  article-title: Mixed-phenotype acute leukemia (MPAL) exhibits frequent mutations in DNMT3A and activated signaling genes
  publication-title: Exp Hematol
– volume: 115
  start-page: 5312
  year: 2010
  ident: bib54
  article-title: Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia
  publication-title: Blood
– volume: 562
  start-page: 373
  year: 2018
  end-page: 379
  ident: bib12
  article-title: The genetic basis and cell of origin of mixed phenotype acute leukaemia
  publication-title: Nature
– volume: 377
  start-page: 454
  year: 2017
  end-page: 464
  ident: bib89
  article-title: Midostaurin plus chemotherapy for acute myeloid leukemia with a FLT3 mutation
  publication-title: N Engl J Med
– volume: 121
  start-page: 4749
  year: 2013
  end-page: 4752
  ident: bib85
  article-title: Whole-exome sequencing in adult ETP-ALL reveals a high rate of DNMT3A mutations
  publication-title: Blood
– volume: 24
  start-page: 103
  year: 2018
  end-page: 112
  ident: bib83
  article-title: The molecular landscape of pediatric acute myeloid leukemia reveals recurrent structural alterations and age-specific mutational interactions
  publication-title: Nat Med
– volume: 117
  start-page: 3163
  year: 2011
  end-page: 3171
  ident: bib5
  article-title: Mixed-phenotype acute leukemia: clinical and laboratory features and outcome in 100 patients defined according to the WHO 2008 classification
  publication-title: Blood
– volume: 11
  start-page: 1440
  year: 2021
  end-page: 1453
  ident: bib97
  article-title: Venetoclax and navitoclax in combination with chemotherapy in patients with relapsed or refractory acute lymphoblastic leukemia and lymphoblastic lymphoma
  publication-title: Cancer Discov
– volume: 368
  start-page: 2059
  year: 2013
  end-page: 2074
  ident: bib79
  article-title: Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia
  publication-title: N Engl J Med
– volume: 12
  year: 2021
  ident: bib48
  article-title: The acquisition of molecular drivers in pediatric therapy-related myeloid neoplasms
  publication-title: Nat Commun
– volume: 136
  start-page: 946
  year: 2020
  end-page: 956
  ident: bib49
  article-title: 13q12.2 deletions in acute lymphoblastic leukemia lead to upregulation of FLT3 through enhancer hijacking
  publication-title: Blood
– volume: 114
  start-page: 2688
  year: 2009
  end-page: 2698
  ident: bib53
  article-title: Deregulated expression of cytokine receptor gene, CRLF2, is involved in lymphoid transformation in B-cell precursor acute lymphoblastic leukemia
  publication-title: Blood
– volume: 91
  start-page: 1861
  year: 2012
  end-page: 1870
  ident: bib91
  article-title: Concomitant inhibition of DNA methyltransferase and BCL-2 protein function synergistically induce mitochondrial apoptosis in acute myelogenous leukemia cells
  publication-title: Ann Hematol
– year: 2016
  ident: bib44
  article-title: HiChIP: efficient and sensitive analysis of protein-directed genome architecture
  publication-title: Nat Methods
– volume: 33
  start-page: 345
  year: 2015
  end-page: 346
  ident: bib39
  article-title: Epigenomic annotation of genetic variants using the Roadmap Epigenome Browser
  publication-title: Nat Biotechnol
– volume: 34
  start-page: 2509
  year: 2020
  end-page: 2512
  ident: bib69
  article-title: T(6;14)(q25;q32) involves BCL11B and is highly associated with mixed-phenotype acute leukemia, T/myeloid
  publication-title: Leukemia
– volume: 67
  start-page: 1
  year: 1986
  end-page: 11
  ident: bib71
  article-title: Lineage promiscuity in hemopoietic differentiation and leukemia
  publication-title: Blood
– volume: 489
  start-page: 57
  year: 2012
  end-page: 74
  ident: bib40
  article-title: An integrated encyclopedia of DNA elements in the human genome
  publication-title: Nature
– volume: 12
  year: 2021
  ident: bib25
  article-title: Epigenetic dynamics in the function of T-lineage regulatory factor Bcl11b
  publication-title: Front Immunol
– volume: 1–6
  year: 2018
  ident: bib96
  article-title: First report of clinical response to venetoclax in early T-cell precursor acute lymphoblastic leukemia
  publication-title: JCO Precis Oncol
– volume: 511
  start-page: 428
  year: 2014
  end-page: 434
  ident: bib36
  article-title: Enhancer hijacking activates GFI1 family oncogenes in medulloblastoma
  publication-title: Nature
– volume: 30
  start-page: 488
  year: 2012
  end-page: 496
  ident: bib93
  article-title: Substantial susceptibility of chronic lymphocytic leukemia to BCL2 inhibition: results of a phase I study of navitoclax in patients with relapsed or refractory disease
  publication-title: J Clin Oncol
– volume: 18
  start-page: 1061
  year: 2017
  end-page: 1075
  ident: bib88
  article-title: Selective inhibition of FLT3 by gilteritinib in relapsed or refractory acute myeloid leukaemia: a multicentre, first-in-human, open-label, phase 1–2 study
  publication-title: Lancet Oncol
– volume: 459
  start-page: 108
  year: 2009
  end-page: 112
  ident: bib38
  article-title: Histone modifications at human enhancers reflect global cell-type-specific gene expression
  publication-title: Nature
– volume: 106
  start-page: 12944
  year: 2009
  end-page: 12949
  ident: bib58
  article-title: Genomic analysis reveals few genetic alterations in pediatric acute myeloid leukemia
  publication-title: Proc Natl Acad Sci U S A
– volume: 301
  start-page: 598
  year: 2003
  end-page: 603
  ident: bib31
  article-title: Homozygous deletions and point mutations of the Rit1/Bcl11b gene in γ-ray induced mouse thymic lymphomas
  publication-title: Biochem Biophys Res Commun
– volume: 27
  start-page: 2648
  year: 2013
  end-page: 2662
  ident: bib56
  article-title: Role of SWI/SNF in acute leukemia maintenance and enhancer-mediated Myc regulation
  publication-title: Genes Dev
– volume: 153
  start-page: 320
  year: 2013
  end-page: 334
  ident: bib42
  article-title: Selective inhibition of tumor oncogenes by disruption of super-enhancers
  publication-title: Cell
– volume: 31
  start-page: 2503
  year: 2017
  end-page: 2514
  ident: bib23
  article-title: The T-ALL related gene BCL11B regulates the initial stages of human T-cell differentiation
  publication-title: Leukemia
– volume: 22
  start-page: 1951
  year: 2016
  end-page: 1957
  ident: bib82
  article-title: Gemtuzumab ozogamicin reduces relapse risk in FLT3/ITD acute myeloid leukemia: a report from the children's oncology group
  publication-title: Clin Cancer Res
– volume: 99
  start-page: 848
  year: 2014
  end-page: 857
  ident: bib67
  article-title: Integrated genome-wide genotyping and gene expression profiling reveals BCL11B as a putative oncogene in acute myeloid leukemia with 14q32 aberrations
  publication-title: Haematologica
– volume: 118
  start-page: 4169
  year: 2011
  end-page: 4173
  ident: bib33
  article-title: The BCL11B tumor suppressor is mutated across the major molecular subtypes of T-cell acute lymphoblastic leukemia
  publication-title: Blood
– volume: 52
  start-page: 811
  year: 2020
  end-page: 818
  ident: bib22
  article-title: Discovery of regulatory noncoding variants in individual cancer genomes by using cis-X
  publication-title: Nat Genet
– volume: 105
  start-page: 54
  year: 2005
  end-page: 60
  ident: bib86
  article-title: Patients with acute myeloid leukemia and an activating mutation in FLT3 respond to a small-molecule FLT3 tyrosine kinase inhibitor, PKC412
  publication-title: Blood
– volume: 80
  start-page: 89
  year: 2010
  end-page: 93
  ident: bib30
  article-title: An early T cell lineage commitment checkpoint dependent on the transcription factor Bcl11b
  publication-title: Science
– volume: 7
  start-page: 1376
  year: 2017
  end-page: 1393
  ident: bib94
  article-title: Found in translation: how preclinical research is guiding the clinical development of the BCL2-selective inhibitor venetoclax
  publication-title: Cancer Discov
– volume: 63
  start-page: 1324
  year: 1984
  end-page: 1330
  ident: bib72
  article-title: Lineage infidelity following exposure of T lymphoblasts (MOLT-3 cells) to 5-azacytidine
  publication-title: Blood
– volume: 78
  start-page: 506
  year: 2020
  end-page: 521
  ident: bib41
  article-title: Large DNA methylation nadirs anchor chromatin loops maintaining hematopoietic stem cell identity
  publication-title: Mol Cell
– volume: 90
  start-page: 29
  year: 1996
  end-page: 32
  ident: bib61
  article-title: Is t(6;14) a non-random translocation in childhood acute mixed lineage leukemia?
  publication-title: Cancer Genet Cytogenet
– volume: 217
  year: 2020
  ident: bib27
  article-title: Cell type–specific actions of Bcl11b in early T-lineage and group 2 innate lymphoid cells
  publication-title: J Exp Med
– volume: 44
  start-page: 1193
  year: 2014
  end-page: 1198
  ident: bib66
  article-title: Identification of novel fusion genes with 28S ribosomal DNA in hematologic malignancies
  publication-title: Int J Oncol
– volume: 80
  start-page: 85
  year: 2010
  end-page: 89
  ident: bib29
  article-title: Reprogramming of T cells to natural killer-like cells upon Bcl11b deletion
  publication-title: Science
– volume: 25
  start-page: 415
  year: 2014
  end-page: 427
  ident: bib46
  article-title: A remote GATA2 hematopoietic enhancer drives leukemogenesis in inv(3)(q21;q26) by activating EVI1 expression
  publication-title: Cancer Cell
– volume: 157
  start-page: 369
  year: 2014
  end-page: 381
  ident: bib47
  article-title: A single oncogenic enhancer rearrangement causes concomitant EVI1 and GATA2 deregulation in Leukemia
  publication-title: Cell
– volume: 11
  start-page: 3933
  year: 2019
  end-page: 3943
  ident: bib9
  article-title: T-lymphoid/myeloid mixed phenotype acute leukemia and early T-cell precursor lymphoblastic leukemia similarities with NOTCH1 mutation as a good prognostic factor
  publication-title: Cancer Manag Res
– volume: 10
  start-page: 147
  year: 2009
  end-page: 156
  ident: bib7
  article-title: Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia
  publication-title: Lancet Oncol
– volume: 119
  start-page: e67
  year: 2012
  end-page: 75
  ident: bib59
  article-title: High-resolution genomic profiling of adult and pediatric core-binding factor acute myeloid leukemia reveals new recurrent genomic alterations
  publication-title: Blood
– volume: 4
  start-page: 1074
  year: 2014
  end-page: 1087
  ident: bib95
  article-title: Maturation stage of T-cell acute lymphoblastic leukemia determines BCL-2 versus BCL-XL dependence and sensitivity to ABT-199
  publication-title: Cancer Discov
– volume: 318
  start-page: 533
  year: 1985
  end-page: 538
  ident: bib51
  article-title: The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice
  publication-title: Nature
– volume: 153
  start-page: 307
  year: 2013
  end-page: 319
  ident: bib43
  article-title: Master transcription factors and mediator establish super-enhancers at key cell identity genes
  publication-title: Cell
– volume: 553
  start-page: 515
  year: 2018
  end-page: 520
  ident: bib57
  article-title: A Myc enhancer cluster regulates normal and leukaemic haematopoietic stem cell hierarchies
  publication-title: Nature
– volume: 35
  start-page: 724
  year: 2021
  end-page: 736
  ident: bib14
  article-title: A transcriptomic continuum of differentiation arrest identifies myeloid interface acute leukemias with poor prognosis
  publication-title: Leukemia
– volume: 49
  start-page: 1211
  year: 2017
  end-page: 1218
  ident: bib11
  article-title: The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia
  publication-title: Nat Genet
– volume: 141
  start-page: 178
  year: 2003
  end-page: 179
  ident: bib62
  article-title: Translocation (6;14) in childhood acute mixed lineage leukemia
  publication-title: Cancer Genet Cytogenet
– volume: 97
  start-page: 1708
  year: 2012
  end-page: 1712
  ident: bib3
  article-title: Clinical, immunophenotypic, cytogenetic, and molecular genetic features in 117 adult patients with mixed-phenotype acute leukemia defined by WHO-2008 classification
  publication-title: Haematologica
– volume: 113
  start-page: 5083
  year: 2009
  end-page: 5089
  ident: bib4
  article-title: Acute mixed lineage leukemia in children: the experience of St Jude Children's Research Hospital
  publication-title: Blood
– volume: 8
  year: 2013
  ident: bib10
  article-title: FLT3 mutations in early T-cell precursor ALL characterize a stem cell like leukemia and imply the clinical use of tyrosine kinase inhibitors
  publication-title: PLoS One
– volume: 350
  start-page: 1617
  year: 2004
  end-page: 1628
  ident: bib21
  article-title: Prognostically useful gene-expression profiles in acute myeloid leukemia
  publication-title: N Engl J Med
– volume: 127
  start-page: 2391
  year: 2016
  end-page: 2405
  ident: bib6
  article-title: The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
  publication-title: Blood
– volume: 81
  start-page: 2332
  year: 2021
  end-page: 2348
  ident: bib45
  article-title: Intrinsically disordered Meningioma-1 stabilizes the BAF complex to cause AML
  publication-title: Mol Cell
– volume: 76
  start-page: 150
  year: 1990
  end-page: 156
  ident: bib60
  article-title: 14q32 translocations are associated with mixed-lineage expression in childhood acute leukemia
  publication-title: Blood
– volume: 24
  start-page: 1844
  year: 2010
  end-page: 1851
  ident: bib2
  article-title: Mixed-phenotype acute leukemia: historical overview and a new definition
  publication-title: Leukemia
– volume: 171
  start-page: 103
  year: 2017
  ident: bib76
  article-title: Non-coding transcription instructs cohesin-dependent chromatin folding and compartmentalization to dictate enhancer-promoter communication and T cell fate
  publication-title: Cell
– volume: 32
  start-page: 1515
  year: 2018
  end-page: 1528
  ident: bib77
  article-title: Therapy for children and adults with mixed phenotype acute leukemia: a systematic review and meta-analysis
  publication-title: Leukemia
– volume: 9
  start-page: 2670
  year: 2018
  ident: bib16
  article-title: Integrative genomic analysis of adult mixed phenotype acute leukemia delineates lineage associated molecular subtypes
  publication-title: Nat Commun
– volume: 481
  start-page: 157
  year: 2012
  end-page: 163
  ident: bib8
  article-title: The genetic basis of early T-cell precursor acute lymphoblastic leukaemia
  publication-title: Nature
– volume: 374
  start-page: 2209
  year: 2016
  end-page: 2221
  ident: bib81
  article-title: Genomic classification and prognosis in acute myeloid leukemia
  publication-title: N Engl J Med
– volume: 2
  start-page: 3526
  year: 2018
  end-page: 3539
  ident: bib15
  article-title: PHF6 and DNMT3A mutations are enriched in distinct subgroups of mixed phenotype acute leukemia with T-lineage differentiation
  publication-title: Blood Adv
– volume: 61
  start-page: 3275
  year: 2020
  end-page: 3277
  ident: bib90
  article-title: The successful use of FLT3 inhibitors in FLT3-positive mixed phenotype acute leukemia
  publication-title: Leuk Lymphoma
– volume: 102
  start-page: 118
  year: 2017
  end-page: 129
  ident: bib18
  article-title: ZNF384-related fusion genes define a subgroup of childhood B-cell precursor acute lymphoblastic leukemia with a characteristic immunotype
  publication-title: Haematologica
– volume: 149
  start-page: 72
  year: 2004
  end-page: 76
  ident: bib63
  article-title: A novel t(6;14)(q25∼q27;q32) in acute myelocytic leukemia involves the BCL11B gene
  publication-title: Cancer Genet Cytogenet
– volume: 122
  start-page: 902
  year: 2013
  end-page: 911
  ident: bib75
  article-title: A far downstream enhancer for murine Bcl11b controls its T-cell specific expression
  publication-title: Blood
– volume: 185
  start-page: 28
  year: 2008
  end-page: 31
  ident: bib64
  article-title: Acute mixed lineage leukemia and a t(6;14)(q25;q32) in two adults
  publication-title: Cancer Genet Cytogenet
– volume: 95
  start-page: 928
  year: 2010
  end-page: 935
  ident: bib78
  article-title: Prognosis of children with mixed phenotype acute leukemia treated on the basis of consistent immunophenotypic criteria
  publication-title: Haematologica
– volume: 16
  start-page: 494
  year: 2016
  end-page: 507
  ident: bib50
  article-title: The genetics and mechanisms of T cell acute lymphoblastic leukaemia
  publication-title: Nat Rev Cancer
– volume: 19
  start-page: 1427
  year: 2018
  end-page: 1440
  ident: bib26
  article-title: Bcl11b sets pro-T cell fate by site-specific cofactor recruitment and by repressing Id2 and Zbtb16
  publication-title: Nat Immunol
– volume: 16
  start-page: 1321
  year: 2010
  end-page: 1327
  ident: bib32
  article-title: The TLX1 oncogene drives aneuploidy in T cell transformation
  publication-title: Nat Med
– volume: 4
  year: 2014
  ident: bib52
  article-title: Oncogenic mechanisms in Burkitt lymphoma
  publication-title: Cold Spring Harb Perspect Med
– start-page: 1
  year: 2021
  end-page: 22
  ident: bib19
  article-title: Enhancer hijacking drives oncogenic BCL11B expression in lineage ambiguous stem cell leukemia
  publication-title: Cancer Discov
– volume: 17
  start-page: 956
  year: 2016
  end-page: 965
  ident: bib24
  article-title: Asynchronous combinatorial action of four regulatory factors activates Bcl11b for T cell commitment
  publication-title: Nat Immunol
– volume: 26
  start-page: 3797
  year: 2007
  end-page: 3810
  ident: bib35
  article-title: Inhibition of BCL11B expression leads to apoptosis of malignant but not normal mature T cells
  publication-title: Oncogene
– volume: 3
  start-page: 75
  year: 2010
  end-page: 86
  ident: bib65
  article-title: Diagnosis of biphenotypic acute leukemia: a paradigmatic approach
  publication-title: Int J Clin Exp Pathol
– volume: 20
  start-page: 620
  year: 2006
  end-page: 626
  ident: bib1
  article-title: Cytogenetics, molecular and ultrastructural characteristics of biphenotypic acute leukemia identified by the EGIL scoring system
  publication-title: Leukemia
– volume: 161
  start-page: 1012
  year: 2015
  end-page: 1025
  ident: bib37
  article-title: Disruptions of topological chromatin domains cause pathogenic rewiring of gene-enhancer interactions
  publication-title: Cell
– volume: 128
  start-page: 2263
  year: 2016
  end-page: 2266
  ident: bib74
  article-title: Distinct bilineal leukemia immunophenotypes are not genetically determined
  publication-title: Blood
– volume: 68
  start-page: 3421
  year: 2008
  end-page: 3428
  ident: bib92
  article-title: ABT-263: a potent and orally bioavailable Bcl-2 family inhibitor
  publication-title: Cancer Res
– volume: 138
  start-page: 773
  year: 2021
  end-page: 784
  ident: bib70
  article-title: 14q32 rearrangements deregulating BCL11B mark a distinct subgroup of T and myeloid immature acute leukemia
  publication-title: Blood
– volume: 1
  year: 2019
  ident: bib20
  article-title: PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia
  publication-title: Nat Genet
– volume: 20
  start-page: 1130
  year: 2014
  end-page: 1137
  ident: bib55
  article-title: A NOTCH1-driven MYC enhancer promotes T cell development, transformation and acute lymphoblastic leukemia
  publication-title: Nat Med
– volume: 28
  start-page: 1586
  year: 2014
  end-page: 1595
  ident: bib80
  article-title: Comprehensive analysis of genetic alterations and their prognostic impacts in adult acute myeloid leukemia patients
  publication-title: Leukemia
– volume: 180
  start-page: 919
  year: 2018
  end-page: 924
  ident: bib13
  article-title: Acute myeloid/T-lymphoblastic leukaemia (AMTL): a distinct category of acute leukaemias with common pathogenesis in need of improved therapy
  publication-title: Br J Haematol
– volume: 7
  start-page: 1
  year: 2014
  end-page: 10
  ident: bib34
  article-title: Low expression of T-cell transcription factor BCL11b predicts inferior survival in adult standard risk T-cell acute lymphoblastic leukemia patients
  publication-title: J Hematol Oncol
– volume: 26
  start-page: 3797
  year: 2007
  ident: 10.1016/j.beha.2021.101329_bib35
  article-title: Inhibition of BCL11B expression leads to apoptosis of malignant but not normal mature T cells
  publication-title: Oncogene
  doi: 10.1038/sj.onc.1210152
– volume: 128
  start-page: 2263
  year: 2016
  ident: 10.1016/j.beha.2021.101329_bib74
  article-title: Distinct bilineal leukemia immunophenotypes are not genetically determined
  publication-title: Blood
  doi: 10.1182/blood-2016-07-725861
– volume: 117
  start-page: 3163
  year: 2011
  ident: 10.1016/j.beha.2021.101329_bib5
  article-title: Mixed-phenotype acute leukemia: clinical and laboratory features and outcome in 100 patients defined according to the WHO 2008 classification
  publication-title: Blood
  doi: 10.1182/blood-2010-10-314682
– volume: 374
  start-page: 2209
  year: 2016
  ident: 10.1016/j.beha.2021.101329_bib81
  article-title: Genomic classification and prognosis in acute myeloid leukemia
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1516192
– volume: 11
  start-page: 3933
  year: 2019
  ident: 10.1016/j.beha.2021.101329_bib9
  article-title: T-lymphoid/myeloid mixed phenotype acute leukemia and early T-cell precursor lymphoblastic leukemia similarities with NOTCH1 mutation as a good prognostic factor
  publication-title: Cancer Manag Res
  doi: 10.2147/CMAR.S196574
– volume: 2
  start-page: 3526
  year: 2018
  ident: 10.1016/j.beha.2021.101329_bib15
  article-title: PHF6 and DNMT3A mutations are enriched in distinct subgroups of mixed phenotype acute leukemia with T-lineage differentiation
  publication-title: Blood Adv
  doi: 10.1182/bloodadvances.2018023531
– volume: 44
  start-page: 1193
  year: 2014
  ident: 10.1016/j.beha.2021.101329_bib66
  article-title: Identification of novel fusion genes with 28S ribosomal DNA in hematologic malignancies
  publication-title: Int J Oncol
  doi: 10.3892/ijo.2014.2291
– volume: 4
  year: 2014
  ident: 10.1016/j.beha.2021.101329_bib52
  article-title: Oncogenic mechanisms in Burkitt lymphoma
  publication-title: Cold Spring Harb Perspect Med
  doi: 10.1101/cshperspect.a014282
– volume: 30
  start-page: 488
  year: 2012
  ident: 10.1016/j.beha.2021.101329_bib93
  article-title: Substantial susceptibility of chronic lymphocytic leukemia to BCL2 inhibition: results of a phase I study of navitoclax in patients with relapsed or refractory disease
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2011.34.7898
– volume: 67
  start-page: 1
  year: 1986
  ident: 10.1016/j.beha.2021.101329_bib71
  article-title: Lineage promiscuity in hemopoietic differentiation and leukemia
  publication-title: Blood
  doi: 10.1182/blood.V67.1.1.1
– year: 2016
  ident: 10.1016/j.beha.2021.101329_bib44
  article-title: HiChIP: efficient and sensitive analysis of protein-directed genome architecture
  publication-title: Nat Methods
  doi: 10.1038/nmeth.3999
– volume: 63
  start-page: 1324
  year: 1984
  ident: 10.1016/j.beha.2021.101329_bib72
  article-title: Lineage infidelity following exposure of T lymphoblasts (MOLT-3 cells) to 5-azacytidine
  publication-title: Blood
  doi: 10.1182/blood.V63.6.1324.1324
– volume: 20
  start-page: 620
  year: 2006
  ident: 10.1016/j.beha.2021.101329_bib1
  article-title: Cytogenetics, molecular and ultrastructural characteristics of biphenotypic acute leukemia identified by the EGIL scoring system
  publication-title: Leukemia
  doi: 10.1038/sj.leu.2404128
– volume: 180
  start-page: 919
  year: 2018
  ident: 10.1016/j.beha.2021.101329_bib13
  article-title: Acute myeloid/T-lymphoblastic leukaemia (AMTL): a distinct category of acute leukaemias with common pathogenesis in need of improved therapy
  publication-title: Br J Haematol
  doi: 10.1111/bjh.15129
– volume: 553
  start-page: 515
  year: 2018
  ident: 10.1016/j.beha.2021.101329_bib57
  article-title: A Myc enhancer cluster regulates normal and leukaemic haematopoietic stem cell hierarchies
  publication-title: Nature
  doi: 10.1038/nature25193
– volume: 35
  start-page: 724
  year: 2021
  ident: 10.1016/j.beha.2021.101329_bib14
  article-title: A transcriptomic continuum of differentiation arrest identifies myeloid interface acute leukemias with poor prognosis
  publication-title: Leukemia
  doi: 10.1038/s41375-020-0965-z
– volume: 11
  start-page: 1440
  year: 2021
  ident: 10.1016/j.beha.2021.101329_bib97
  article-title: Venetoclax and navitoclax in combination with chemotherapy in patients with relapsed or refractory acute lymphoblastic leukemia and lymphoblastic lymphoma
  publication-title: Cancer Discov
  doi: 10.1158/2159-8290.CD-20-1465
– volume: 68
  start-page: 3421
  year: 2008
  ident: 10.1016/j.beha.2021.101329_bib92
  article-title: ABT-263: a potent and orally bioavailable Bcl-2 family inhibitor
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-07-5836
– volume: 31
  start-page: 2503
  year: 2017
  ident: 10.1016/j.beha.2021.101329_bib23
  article-title: The T-ALL related gene BCL11B regulates the initial stages of human T-cell differentiation
  publication-title: Leukemia
  doi: 10.1038/leu.2017.70
– volume: 49
  start-page: 1211
  year: 2017
  ident: 10.1016/j.beha.2021.101329_bib11
  article-title: The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia
  publication-title: Nat Genet
  doi: 10.1038/ng.3909
– volume: 95
  start-page: 928
  year: 2010
  ident: 10.1016/j.beha.2021.101329_bib78
  article-title: Prognosis of children with mixed phenotype acute leukemia treated on the basis of consistent immunophenotypic criteria
  publication-title: Haematologica
  doi: 10.3324/haematol.2009.014506
– volume: 136
  start-page: 946
  year: 2020
  ident: 10.1016/j.beha.2021.101329_bib49
  article-title: 13q12.2 deletions in acute lymphoblastic leukemia lead to upregulation of FLT3 through enhancer hijacking
  publication-title: Blood
  doi: 10.1182/blood.2019004684
– volume: 34
  start-page: 2509
  year: 2020
  ident: 10.1016/j.beha.2021.101329_bib69
  article-title: T(6;14)(q25;q32) involves BCL11B and is highly associated with mixed-phenotype acute leukemia, T/myeloid
  publication-title: Leukemia
  doi: 10.1038/s41375-020-0761-9
– volume: 138
  start-page: 773
  issue: 9
  year: 2021
  ident: 10.1016/j.beha.2021.101329_bib70
  article-title: 14q32 rearrangements deregulating BCL11B mark a distinct subgroup of T and myeloid immature acute leukemia
  publication-title: Blood
– volume: 20
  start-page: 1130
  year: 2014
  ident: 10.1016/j.beha.2021.101329_bib55
  article-title: A NOTCH1-driven MYC enhancer promotes T cell development, transformation and acute lymphoblastic leukemia
  publication-title: Nat Med
  doi: 10.1038/nm.3665
– volume: 511
  start-page: 428
  year: 2014
  ident: 10.1016/j.beha.2021.101329_bib36
  article-title: Enhancer hijacking activates GFI1 family oncogenes in medulloblastoma
  publication-title: Nature
  doi: 10.1038/nature13379
– volume: 7
  start-page: 1
  year: 2014
  ident: 10.1016/j.beha.2021.101329_bib34
  article-title: Low expression of T-cell transcription factor BCL11b predicts inferior survival in adult standard risk T-cell acute lymphoblastic leukemia patients
  publication-title: J Hematol Oncol
  doi: 10.1186/s13045-014-0051-y
– volume: 119
  start-page: e67
  year: 2012
  ident: 10.1016/j.beha.2021.101329_bib59
  article-title: High-resolution genomic profiling of adult and pediatric core-binding factor acute myeloid leukemia reveals new recurrent genomic alterations
  publication-title: Blood
  doi: 10.1182/blood-2011-09-380444
– volume: 489
  start-page: 57
  year: 2012
  ident: 10.1016/j.beha.2021.101329_bib40
  article-title: An integrated encyclopedia of DNA elements in the human genome
  publication-title: Nature
  doi: 10.1038/nature11247
– volume: 153
  start-page: 320
  year: 2013
  ident: 10.1016/j.beha.2021.101329_bib42
  article-title: Selective inhibition of tumor oncogenes by disruption of super-enhancers
  publication-title: Cell
  doi: 10.1016/j.cell.2013.03.036
– start-page: 1
  issue: 11
  year: 2021
  ident: 10.1016/j.beha.2021.101329_bib19
  article-title: Enhancer hijacking drives oncogenic BCL11B expression in lineage ambiguous stem cell leukemia
  publication-title: Cancer Discov
– volume: 185
  start-page: 28
  year: 2008
  ident: 10.1016/j.beha.2021.101329_bib64
  article-title: Acute mixed lineage leukemia and a t(6;14)(q25;q32) in two adults
  publication-title: Cancer Genet Cytogenet
  doi: 10.1016/j.cancergencyto.2008.04.010
– volume: 171
  start-page: 103
  year: 2017
  ident: 10.1016/j.beha.2021.101329_bib76
  article-title: Non-coding transcription instructs cohesin-dependent chromatin folding and compartmentalization to dictate enhancer-promoter communication and T cell fate
  publication-title: Cell
  doi: 10.1016/j.cell.2017.09.001
– volume: 377
  start-page: 454
  year: 2017
  ident: 10.1016/j.beha.2021.101329_bib89
  article-title: Midostaurin plus chemotherapy for acute myeloid leukemia with a FLT3 mutation
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1614359
– volume: 65
  year: 2018
  ident: 10.1016/j.beha.2021.101329_bib73
  article-title: Myeloid lineage switch following chimeric antigen receptor T-cell therapy in a patient with TCF3-ZNF384 fusion-positive B-lymphoblastic leukemia
  publication-title: Pediatr Blood Cancer
  doi: 10.1002/pbc.27265
– volume: 113
  start-page: 5083
  year: 2009
  ident: 10.1016/j.beha.2021.101329_bib4
  article-title: Acute mixed lineage leukemia in children: the experience of St Jude Children's Research Hospital
  publication-title: Blood
  doi: 10.1182/blood-2008-10-187351
– volume: 16
  start-page: 1691
  year: 2015
  ident: 10.1016/j.beha.2021.101329_bib87
  article-title: Addition of sorafenib versus placebo to standard therapy in patients aged 60 years or younger with newly diagnosed acute myeloid leukaemia (SORAML): a multicentre, phase 2, randomised controlled trial
  publication-title: Lancet Oncol
  doi: 10.1016/S1470-2045(15)00362-9
– volume: 19
  start-page: 1427
  year: 2018
  ident: 10.1016/j.beha.2021.101329_bib26
  article-title: Bcl11b sets pro-T cell fate by site-specific cofactor recruitment and by repressing Id2 and Zbtb16
  publication-title: Nat Immunol
  doi: 10.1038/s41590-018-0238-4
– volume: 22
  start-page: 723
  year: 2008
  ident: 10.1016/j.beha.2021.101329_bib17
  article-title: E2A-ZNF384 and NOL1-E2A fusion created by a cryptic t(12;19)(p13.3; p13.3) in acute leukemia
  publication-title: Leukemia
  doi: 10.1038/sj.leu.2405084
– volume: 4
  start-page: 1074
  year: 2014
  ident: 10.1016/j.beha.2021.101329_bib95
  article-title: Maturation stage of T-cell acute lymphoblastic leukemia determines BCL-2 versus BCL-XL dependence and sensitivity to ABT-199
  publication-title: Cancer Discov
  doi: 10.1158/2159-8290.CD-14-0353
– volume: 59
  start-page: 1231
  year: 2018
  ident: 10.1016/j.beha.2021.101329_bib68
  article-title: Genomic characterization of chromosome translocations in patients with T/myeloid mixed-phenotype acute leukemia
  publication-title: Leuk Lymphoma
  doi: 10.1080/10428194.2017.1372577
– volume: 114
  start-page: 2688
  year: 2009
  ident: 10.1016/j.beha.2021.101329_bib53
  article-title: Deregulated expression of cytokine receptor gene, CRLF2, is involved in lymphoid transformation in B-cell precursor acute lymphoblastic leukemia
  publication-title: Blood
  doi: 10.1182/blood-2009-03-208397
– volume: 90
  start-page: 29
  year: 1996
  ident: 10.1016/j.beha.2021.101329_bib61
  article-title: Is t(6;14) a non-random translocation in childhood acute mixed lineage leukemia?
  publication-title: Cancer Genet Cytogenet
  doi: 10.1016/0165-4608(96)00030-1
– volume: 27
  start-page: 2648
  year: 2013
  ident: 10.1016/j.beha.2021.101329_bib56
  article-title: Role of SWI/SNF in acute leukemia maintenance and enhancer-mediated Myc regulation
  publication-title: Genes Dev
  doi: 10.1101/gad.232710.113
– volume: 121
  start-page: 4749
  year: 2013
  ident: 10.1016/j.beha.2021.101329_bib85
  article-title: Whole-exome sequencing in adult ETP-ALL reveals a high rate of DNMT3A mutations
  publication-title: Blood
  doi: 10.1182/blood-2012-11-465138
– volume: 12
  year: 2021
  ident: 10.1016/j.beha.2021.101329_bib48
  article-title: The acquisition of molecular drivers in pediatric therapy-related myeloid neoplasms
  publication-title: Nat Commun
  doi: 10.1038/s41467-021-21255-8
– volume: 161
  start-page: 1012
  year: 2015
  ident: 10.1016/j.beha.2021.101329_bib37
  article-title: Disruptions of topological chromatin domains cause pathogenic rewiring of gene-enhancer interactions
  publication-title: Cell
  doi: 10.1016/j.cell.2015.04.004
– volume: 18
  start-page: 1061
  year: 2017
  ident: 10.1016/j.beha.2021.101329_bib88
  article-title: Selective inhibition of FLT3 by gilteritinib in relapsed or refractory acute myeloid leukaemia: a multicentre, first-in-human, open-label, phase 1–2 study
  publication-title: Lancet Oncol
  doi: 10.1016/S1470-2045(17)30416-3
– volume: 99
  start-page: 848
  year: 2014
  ident: 10.1016/j.beha.2021.101329_bib67
  article-title: Integrated genome-wide genotyping and gene expression profiling reveals BCL11B as a putative oncogene in acute myeloid leukemia with 14q32 aberrations
  publication-title: Haematologica
  doi: 10.3324/haematol.2013.095604
– volume: 118
  start-page: 4169
  year: 2011
  ident: 10.1016/j.beha.2021.101329_bib33
  article-title: The BCL11B tumor suppressor is mutated across the major molecular subtypes of T-cell acute lymphoblastic leukemia
  publication-title: Blood
  doi: 10.1182/blood-2010-11-318873
– volume: 217
  year: 2020
  ident: 10.1016/j.beha.2021.101329_bib27
  article-title: Cell type–specific actions of Bcl11b in early T-lineage and group 2 innate lymphoid cells
  publication-title: J Exp Med
  doi: 10.1084/jem.20190972
– volume: 122
  start-page: 902
  year: 2013
  ident: 10.1016/j.beha.2021.101329_bib75
  article-title: A far downstream enhancer for murine Bcl11b controls its T-cell specific expression
  publication-title: Blood
  doi: 10.1182/blood-2012-08-447839
– volume: 44
  start-page: 740
  year: 2016
  ident: 10.1016/j.beha.2021.101329_bib84
  article-title: Mixed-phenotype acute leukemia (MPAL) exhibits frequent mutations in DNMT3A and activated signaling genes
  publication-title: Exp Hematol
  doi: 10.1016/j.exphem.2016.05.003
– volume: 9
  start-page: 2670
  year: 2018
  ident: 10.1016/j.beha.2021.101329_bib16
  article-title: Integrative genomic analysis of adult mixed phenotype acute leukemia delineates lineage associated molecular subtypes
  publication-title: Nat Commun
  doi: 10.1038/s41467-018-04924-z
– volume: 12
  year: 2021
  ident: 10.1016/j.beha.2021.101329_bib25
  article-title: Epigenetic dynamics in the function of T-lineage regulatory factor Bcl11b
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2021.669498
– volume: 52
  start-page: 811
  year: 2020
  ident: 10.1016/j.beha.2021.101329_bib22
  article-title: Discovery of regulatory noncoding variants in individual cancer genomes by using cis-X
  publication-title: Nat Genet
  doi: 10.1038/s41588-020-0659-5
– volume: 115
  start-page: 5312
  year: 2010
  ident: 10.1016/j.beha.2021.101329_bib54
  article-title: Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia
  publication-title: Blood
  doi: 10.1182/blood-2009-09-245944
– volume: 149
  start-page: 72
  year: 2004
  ident: 10.1016/j.beha.2021.101329_bib63
  article-title: A novel t(6;14)(q25∼q27;q32) in acute myelocytic leukemia involves the BCL11B gene
  publication-title: Cancer Genet Cytogenet
  doi: 10.1016/S0165-4608(03)00302-9
– volume: 368
  start-page: 2059
  year: 2013
  ident: 10.1016/j.beha.2021.101329_bib79
  article-title: Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1301689
– volume: 106
  start-page: 12944
  year: 2009
  ident: 10.1016/j.beha.2021.101329_bib58
  article-title: Genomic analysis reveals few genetic alterations in pediatric acute myeloid leukemia
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.0903142106
– volume: 7
  start-page: 1376
  year: 2017
  ident: 10.1016/j.beha.2021.101329_bib94
  article-title: Found in translation: how preclinical research is guiding the clinical development of the BCL2-selective inhibitor venetoclax
  publication-title: Cancer Discov
  doi: 10.1158/2159-8290.CD-17-0797
– volume: 350
  start-page: 1617
  year: 2004
  ident: 10.1016/j.beha.2021.101329_bib21
  article-title: Prognostically useful gene-expression profiles in acute myeloid leukemia
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa040465
– volume: 81
  start-page: 2332
  year: 2021
  ident: 10.1016/j.beha.2021.101329_bib45
  article-title: Intrinsically disordered Meningioma-1 stabilizes the BAF complex to cause AML
  publication-title: Mol Cell
  doi: 10.1016/j.molcel.2021.04.014
– volume: 157
  start-page: 369
  year: 2014
  ident: 10.1016/j.beha.2021.101329_bib47
  article-title: A single oncogenic enhancer rearrangement causes concomitant EVI1 and GATA2 deregulation in Leukemia
  publication-title: Cell
  doi: 10.1016/j.cell.2014.02.019
– volume: 17
  start-page: 956
  year: 2016
  ident: 10.1016/j.beha.2021.101329_bib24
  article-title: Asynchronous combinatorial action of four regulatory factors activates Bcl11b for T cell commitment
  publication-title: Nat Immunol
  doi: 10.1038/ni.3514
– volume: 153
  start-page: 307
  year: 2013
  ident: 10.1016/j.beha.2021.101329_bib43
  article-title: Master transcription factors and mediator establish super-enhancers at key cell identity genes
  publication-title: Cell
  doi: 10.1016/j.cell.2013.03.035
– volume: 204
  start-page: 3003
  year: 2007
  ident: 10.1016/j.beha.2021.101329_bib28
  article-title: BCL11B is required for positive selection and survival of double-positive thymocytes
  publication-title: J Exp Med
  doi: 10.1084/jem.20070863
– volume: 3
  start-page: 75
  year: 2010
  ident: 10.1016/j.beha.2021.101329_bib65
  article-title: Diagnosis of biphenotypic acute leukemia: a paradigmatic approach
  publication-title: Int J Clin Exp Pathol
– volume: 24
  start-page: 1844
  year: 2010
  ident: 10.1016/j.beha.2021.101329_bib2
  article-title: Mixed-phenotype acute leukemia: historical overview and a new definition
  publication-title: Leukemia
  doi: 10.1038/leu.2010.202
– volume: 10
  start-page: 147
  year: 2009
  ident: 10.1016/j.beha.2021.101329_bib7
  article-title: Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia
  publication-title: Lancet Oncol
  doi: 10.1016/S1470-2045(08)70314-0
– volume: 22
  start-page: 1951
  year: 2016
  ident: 10.1016/j.beha.2021.101329_bib82
  article-title: Gemtuzumab ozogamicin reduces relapse risk in FLT3/ITD acute myeloid leukemia: a report from the children's oncology group
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-15-1349
– volume: 481
  start-page: 157
  year: 2012
  ident: 10.1016/j.beha.2021.101329_bib8
  article-title: The genetic basis of early T-cell precursor acute lymphoblastic leukaemia
  publication-title: Nature
  doi: 10.1038/nature10725
– volume: 127
  start-page: 2391
  year: 2016
  ident: 10.1016/j.beha.2021.101329_bib6
  article-title: The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
  publication-title: Blood
  doi: 10.1182/blood-2016-03-643544
– volume: 301
  start-page: 598
  year: 2003
  ident: 10.1016/j.beha.2021.101329_bib31
  article-title: Homozygous deletions and point mutations of the Rit1/Bcl11b gene in γ-ray induced mouse thymic lymphomas
  publication-title: Biochem Biophys Res Commun
  doi: 10.1016/S0006-291X(02)03069-3
– volume: 78
  start-page: 506
  year: 2020
  ident: 10.1016/j.beha.2021.101329_bib41
  article-title: Large DNA methylation nadirs anchor chromatin loops maintaining hematopoietic stem cell identity
  publication-title: Mol Cell
  doi: 10.1016/j.molcel.2020.04.018
– volume: 1
  year: 2019
  ident: 10.1016/j.beha.2021.101329_bib20
  article-title: PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia
  publication-title: Nat Genet
– volume: 459
  start-page: 108
  year: 2009
  ident: 10.1016/j.beha.2021.101329_bib38
  article-title: Histone modifications at human enhancers reflect global cell-type-specific gene expression
  publication-title: Nature
  doi: 10.1038/nature07829
– volume: 16
  start-page: 1321
  year: 2010
  ident: 10.1016/j.beha.2021.101329_bib32
  article-title: The TLX1 oncogene drives aneuploidy in T cell transformation
  publication-title: Nat Med
  doi: 10.1038/nm.2246
– volume: 105
  start-page: 54
  year: 2005
  ident: 10.1016/j.beha.2021.101329_bib86
  article-title: Patients with acute myeloid leukemia and an activating mutation in FLT3 respond to a small-molecule FLT3 tyrosine kinase inhibitor, PKC412
  publication-title: Blood
  doi: 10.1182/blood-2004-03-0891
– volume: 562
  start-page: 373
  year: 2018
  ident: 10.1016/j.beha.2021.101329_bib12
  article-title: The genetic basis and cell of origin of mixed phenotype acute leukaemia
  publication-title: Nature
  doi: 10.1038/s41586-018-0436-0
– volume: 33
  start-page: 345
  year: 2015
  ident: 10.1016/j.beha.2021.101329_bib39
  article-title: Epigenomic annotation of genetic variants using the Roadmap Epigenome Browser
  publication-title: Nat Biotechnol
  doi: 10.1038/nbt.3158
– volume: 32
  start-page: 1515
  year: 2018
  ident: 10.1016/j.beha.2021.101329_bib77
  article-title: Therapy for children and adults with mixed phenotype acute leukemia: a systematic review and meta-analysis
  publication-title: Leukemia
  doi: 10.1038/s41375-018-0058-4
– volume: 102
  start-page: 118
  year: 2017
  ident: 10.1016/j.beha.2021.101329_bib18
  article-title: ZNF384-related fusion genes define a subgroup of childhood B-cell precursor acute lymphoblastic leukemia with a characteristic immunotype
  publication-title: Haematologica
  doi: 10.3324/haematol.2016.151035
– volume: 1–6
  year: 2018
  ident: 10.1016/j.beha.2021.101329_bib96
  article-title: First report of clinical response to venetoclax in early T-cell precursor acute lymphoblastic leukemia
  publication-title: JCO Precis Oncol
– volume: 80
  start-page: 89
  issue: 329
  year: 2010
  ident: 10.1016/j.beha.2021.101329_bib30
  article-title: An early T cell lineage commitment checkpoint dependent on the transcription factor Bcl11b
  publication-title: Science
  doi: 10.1126/science.1188989
– volume: 80
  start-page: 85
  issue: 329
  year: 2010
  ident: 10.1016/j.beha.2021.101329_bib29
  article-title: Reprogramming of T cells to natural killer-like cells upon Bcl11b deletion
  publication-title: Science
  doi: 10.1126/science.1188063
– volume: 97
  start-page: 1708
  year: 2012
  ident: 10.1016/j.beha.2021.101329_bib3
  article-title: Clinical, immunophenotypic, cytogenetic, and molecular genetic features in 117 adult patients with mixed-phenotype acute leukemia defined by WHO-2008 classification
  publication-title: Haematologica
  doi: 10.3324/haematol.2012.064485
– volume: 141
  start-page: 178
  year: 2003
  ident: 10.1016/j.beha.2021.101329_bib62
  article-title: Translocation (6;14) in childhood acute mixed lineage leukemia
  publication-title: Cancer Genet Cytogenet
  doi: 10.1016/S0165-4608(02)00790-2
– volume: 91
  start-page: 1861
  year: 2012
  ident: 10.1016/j.beha.2021.101329_bib91
  article-title: Concomitant inhibition of DNA methyltransferase and BCL-2 protein function synergistically induce mitochondrial apoptosis in acute myelogenous leukemia cells
  publication-title: Ann Hematol
  doi: 10.1007/s00277-012-1537-8
– volume: 16
  start-page: 494
  year: 2016
  ident: 10.1016/j.beha.2021.101329_bib50
  article-title: The genetics and mechanisms of T cell acute lymphoblastic leukaemia
  publication-title: Nat Rev Cancer
  doi: 10.1038/nrc.2016.63
– volume: 24
  start-page: 103
  year: 2018
  ident: 10.1016/j.beha.2021.101329_bib83
  article-title: The molecular landscape of pediatric acute myeloid leukemia reveals recurrent structural alterations and age-specific mutational interactions
  publication-title: Nat Med
  doi: 10.1038/nm.4439
– volume: 318
  start-page: 533
  year: 1985
  ident: 10.1016/j.beha.2021.101329_bib51
  article-title: The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice
  publication-title: Nature
  doi: 10.1038/318533a0
– volume: 8
  year: 2013
  ident: 10.1016/j.beha.2021.101329_bib10
  article-title: FLT3 mutations in early T-cell precursor ALL characterize a stem cell like leukemia and imply the clinical use of tyrosine kinase inhibitors
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0053190
– volume: 28
  start-page: 1586
  year: 2014
  ident: 10.1016/j.beha.2021.101329_bib80
  article-title: Comprehensive analysis of genetic alterations and their prognostic impacts in adult acute myeloid leukemia patients
  publication-title: Leukemia
  doi: 10.1038/leu.2014.55
– volume: 25
  start-page: 415
  year: 2014
  ident: 10.1016/j.beha.2021.101329_bib46
  article-title: A remote GATA2 hematopoietic enhancer drives leukemogenesis in inv(3)(q21;q26) by activating EVI1 expression
  publication-title: Cancer Cell
  doi: 10.1016/j.ccr.2014.02.008
– volume: 76
  start-page: 150
  year: 1990
  ident: 10.1016/j.beha.2021.101329_bib60
  article-title: 14q32 translocations are associated with mixed-lineage expression in childhood acute leukemia
  publication-title: Blood
  doi: 10.1182/blood.V76.1.150.150
– volume: 61
  start-page: 3275
  year: 2020
  ident: 10.1016/j.beha.2021.101329_bib90
  article-title: The successful use of FLT3 inhibitors in FLT3-positive mixed phenotype acute leukemia
  publication-title: Leuk Lymphoma
  doi: 10.1080/10428194.2020.1802451
SSID ssj0033923
Score 2.3913856
SecondaryResourceType review_article
Snippet Acute leukemias of ambiguous lineage (ALAL), including mixed phenotype acute leukemia (MPAL) and related entities such as early T-cell precursor acute leukemia...
SourceID pubmedcentral
proquest
pubmed
crossref
elsevier
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 101329
SubjectTerms 14q32
ALAL
BCL11B
Child
Enhancer hijacking
Genomics
Humans
Immunophenotyping
Lineage ambiguous
Mixed phenotype acute leukemia
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Prospective Studies
Repressor Proteins
Tumor Suppressor Proteins
Title Redefining the biological basis of lineage-ambiguous leukemia through genomics: BCL11B deregulation in acute leukemias of ambiguous lineage
URI https://www.clinicalkey.com/#!/content/1-s2.0-S1521692621000943
https://dx.doi.org/10.1016/j.beha.2021.101329
https://www.ncbi.nlm.nih.gov/pubmed/34865701
https://www.proquest.com/docview/2607311431
https://pubmed.ncbi.nlm.nih.gov/PMC8649174
Volume 34
WOSCitedRecordID wos000727210100012&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVESC
  databaseName: Elsevier SD Freedom Collection Journals 2021
  customDbUrl:
  eissn: 1532-1924
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0033923
  issn: 1521-6926
  databaseCode: AIEXJ
  dateStart: 19990301
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1JT9tAFB4FqBCXqitNFzSVeosc2WM7M-4tRKnaClBVUSk3y-OFmCZOBAniP_Az-KN9bxbHIYW2h14sy_a8SeZ9nrf4LYR8CN0iyljqOiLNuRNkRQZngesUXi4koBq2ZZUofMRPTsRoFH1rtW5tLszVhFeVuL6O5v-V1XANmI2ps__A7pooXIBzYDocge1w_CvGf4f_Xai2D0qp1FWWFCtAYunqI6hawj7iJFNZni0xCHaSL3_m0zKp-_Zg7dYpBhH5_c7h4MjzDjvY1vPMdPtCN0mSYoyBHakINwjqKda-GYMAqrOyFORMpaFxtzOwCZrjBIvIrvn6j7GAVlHOdE48OhEuYSMbrqCCJUXHSTN6wHQMM94M5jUiQ3K7AzMHrcLmFm38nWXT_zDXLXPBmo5-Kwq0V-K8i-UOujhVd_NhWMP5VOHADwQGAXkrsVgHK9pbW2SH8TCCrXOn_2U4-moFvg8qpm_ysXTo4N0p98iuJXKf-rNp3tyN0m2oPadPyGNjr9C-xtlT0sqrZ2T32ERkPCc3K7hRgBtdwY0quNFZQTfgRi1oqIEbtXD7SDXYaBNstKyoAls9TpFtkNMTvCA_Pg1PB58d0-DDSUO3t3DCQmQBh3PXZ6mQMkwziQ0MsqiQYSF9CSuWpnCThwko2gUPQBgzyUTGche2GP8l2a5mVf6KUMngepagPQEGfgJiKRIsk0EWhFwmgreJZ9c9Tk31e2zCMoltmON5jGyLkW2xZlubdOoxc1375cGnfcvO2GY1gxyOAY8PjgrrUUbn1brsH8e9t4iJQSDgV76kymHJY9YDqe2BGeS1yb5GUP3rLQrbhK9hq34Ai82v36nKsSo6L3pB5PHg9b0035C91Qv9lmwvLpb5O_IovVqUlxcHZIuPxIF5c34B3HH07Q
linkProvider Elsevier
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Redefining+the+biological+basis+of+lineage-ambiguous+leukemia+through+genomics%3A+BCL11B+deregulation+in+acute+leukemias+of+ambiguous+lineage&rft.jtitle=Best+practice+%26+research.+Clinical+haematology&rft.au=Montefiori%2C+Lindsey+E&rft.au=Mullighan%2C+Charles+G&rft.date=2021-12-01&rft.eissn=1532-1924&rft.volume=34&rft.issue=4&rft.spage=101329&rft_id=info:doi/10.1016%2Fj.beha.2021.101329&rft_id=info%3Apmid%2F34865701&rft.externalDocID=34865701
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1521-6926&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1521-6926&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1521-6926&client=summon